Targeted Oral Anticancer Agents: Patterns of Indicated and Off-Label Use, the Associated Factors and Economic Implications
$278,472R01FY2023CANIH
University Of California Los Angeles, Los Angeles CA
Investigators
Linked publications & trials
Paper 39003520Paper 37676663Paper 37471094Paper 37284847Paper 36583541Paper 36480188Paper 36346180Paper 36099549Paper 35774487Paper 35417565Paper 35325197Paper 34981116Paper 34456058Paper 34378163Paper 34350376Paper 34043452Paper 33783054Paper 33270520Paper 33226648Paper 31804869Paper 31286464Paper 31208943
View original record on NIH RePORTER →